Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Curr HIV/AIDS Rep. 2014 Sep;11(3):291–307. doi: 10.1007/s11904-014-0220-1

Table 2.

Pooled estimates for the association between depression adherence to antiretroviral therapy and series of subgroup analyses

Subgroup n Odds ratio (95% CI) I2 (%)
Overall 111 0.58 (0.54 to 0.62) 86.9
Country’s income group
 High-income 92 0.59 (0.55 to 0.63) 87.8
 Middle-income 10 0.39 (0.25 to 0.63) 75.6
 Low-income 8 0.52 (0.40 to 0.68) 28.2
Publication year
 1993 to 2000 7 0.33 (0.13 to 0.83) 93.4
 2001 to 2005 46 0.58 (0.52 to 0.64) 85.6
 2006 to 2010 50 0.58 (0.52 to 0.64) 73.4
 2011 to 2013 8 0.61 (0.46 to 0.82) 79.3
Study design
 Cross-sectional 86 0.53 (0.48 to 0.58) 85.5
 Cohort 24 0.77 (0.71 to 0.83) 77.1
Sample size
 Less than 100 25 0.41 (0.27 to 0.62) 81.9
 100 to 500 67 0.61 (0.57 to 0.65) 82.8
 500 or more 19 0.70 (0.62 to 0.79) 73.4
Depression rate
 Less than 20% 5 0.63 (0.49 to 0.98) 83.4
 20 to 50 % 18 0.66 (0.55 to 0.78) 70.4
 50% plus 12 0.48 (0.41 to 0.57) 0.0
Adherence rate
 Less than 50% 6 0.52 (0.43 to 0.62) 0.0
 50 to 75% 27 0.75 (0.69 to 0.82) 73.9
 75% plus 23 0.62 (0.54 to 0.72) 80.3
Adherence measure
 Self-reported 92 0.61 (0.57 to 0.64) 83.9
 MEMS cap 7 0.48 (0.18 to 1.31) 96.5
 Pharmacy refills 8 0.62 (0.52 to 0.76) 29.1
 Pill count 4 0.56 (0.42 to 0.74) 0.0